Vycor Medical (VYCO) Income from Continuing Operations (2010 - 2026)
Vycor Medical (VYCO) posted quarterly Income from Continuing Operations of 20095.0 for Q1 2026, up 152.18% year-over-year from 7968.65 in Q1 2025, and up 132.21% quarter-over-quarter from 62379.0 in Q4 2025.
Vycor Medical (VYCO) Income from Continuing Operations (2010 - 2026) Analysis & Trends
Vycor Medical (VYCO) has reported Income from Continuing Operations for 17 consecutive years, with 20095.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Income from Continuing Operations rose 152.18% year-over-year to 20095.0; the TTM figure through Mar 2026 stood at 11581.0 (up 87.11% YoY), while the FY2025 annual figure was 55450.0, up 6.61% from the prior year.
- Income from Continuing Operations rose to 20095.0 in Q1 2026 per VYCO's latest filing, from 62379.0 in the prior quarter.
- Across five years, Income from Continuing Operations topped out at 261471.0 in Q4 2022 and bottomed at 112312.0 in Q3 2022.
- Historically, Income from Continuing Operations has averaged 12786.65 across 5 years, with a median of 30507.0 in 2024.
- Annual changes were most pronounced in 2022 — Income from Continuing Operations slumped 10463.31% — and 2025, when it surged 357.41%.
- Vycor Medical's Income from Continuing Operations stood at 261471.0 in 2022, then tumbled by 134.41% to 89961.0 in 2023, then soared by 120.49% to 18432.0 in 2024, then slumped by 438.43% to 62379.0 in 2025, then surged by 132.21% to 20095.0 in 2026.
- Business Quant data shows VYCO's Income from Continuing Operations at 20095.0 in Q1 2026, 62379.0 in Q4 2025, and 4990.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 1.28 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 905.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 241.40 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 249.10 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 574.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 1.04 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 201.00 Mn |
| 10 | Vycor Medical | 2.34 Mn | 2.18 Mn | 344,445.00 | -19,109.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 20,095.00 |
| Dec 31, 2025 | -62,379.00 |
| Sep 30, 2025 | 4,990.00 |
| Jun 30, 2025 | 25,713.00 |
| Mar 31, 2025 | -38,514.00 |
| Dec 31, 2024 | 18,432.00 |
| Sep 30, 2024 | -59,770.00 |
| Jun 30, 2024 | -9,989.00 |
| Mar 31, 2024 | -30,507.00 |
| Dec 31, 2023 | -89,961.00 |
| Sep 30, 2023 | -51,479.00 |
| Jun 30, 2023 | 70,791.00 |
| Mar 31, 2023 | 7,569.00 |
| Dec 31, 2022 | 261,471.00 |
| Sep 30, 2022 | -112,312.00 |
| Jun 30, 2022 | -97,726.00 |
| Mar 31, 2022 | -73,797.00 |
| Dec 31, 2021 | 185,019.00 |
| Sep 30, 2021 | 7,659.00 |
| Jun 30, 2021 | 943.00 |